In addition, FDA is proposing two other constraints within the submission of the supplemental PMTA. Below proposed § 1114.fifteen(a), a supplemental PMTA couldn't be submitted the place the marketing buy for the first tobacco item has been withdrawn or continues to be briefly suspend